跳至主要内容
临床试验/NCT06778954
NCT06778954招募中不适用

Prospective Randomized Controlled Trial of Ropivacaine-Poloxamer 407 Based Gel Application on Postoperative Pain After Open Gastrectomy

Gangnam Severance Hospital1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2025年1月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
48
试验地点
1
主要终点
Total fentanyl consumption within 72 hours postoperatively.

研究概览

简要总结

The study evaluates the efficacy of Ropivacaine-Poloxamer 407 hydrogel in reducing postoperative pain following open gastrectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with a histologically confirmed diagnosis of gastric adenocarcinoma prior to surgery.
  • Patients who have undergone a complete surgical resection (R0 resection).
  • Patients with an ASA (American Society of Anesthesiologists) score of 3 or below.
  • Patients aged 20 years or older.

排除标准

  • Patients under 19 years of age.
  • Presence of ascites or peritoneal metastasis.
  • Patients who have undergone preoperative chemotherapy or radiotherapy.
  • Diagnosis of malignancies other than gastric cancer.
  • Uncontrolled diabetes, autoimmune diseases, hypertrophic scars, or keloid history affecting wound healing.
  • History of allergy or adverse reactions to Ropivacaine or other local anesthetics.
  • Pregnant women.
  • Patients with preoperative chronic pain conditions, including CRPS.
  • Patients with long-term preoperative use of opioid analgesics.
  • Patients with psychiatric disorders deemed likely to interfere with study participation.
  • Patients with severe liver disease, renal disease, or arrhythmia.

结局指标

主要结局

Total fentanyl consumption within 72 hours postoperatively.

时间窗: Total fentanyl consumption within 72 hours postoperatively.

The total amount of fentanyl administered to the patient via IV PCA during the initial 72-hour postoperative period will be recorded and compared among groups to assess analgesic efficacy.

次要结局

  • Pain intensity scores (NRS) at rest and during movement.(Pain intensity: Measured at 24, 48, and 72 hours postoperatively.)
  • Time to first flatus and bowel movement.(Bowel function: Time to first flatus and bowel movement recorded until discahrge (within 6 days))
  • Occurrence of postoperative nausea and vomiting (PONV).(PONV: Assessed daily for 72 hours.)
  • Wound healing assessment, including seroma and infection rates.(Wound healing: Evaluated at regular intervals until first outpatient day (within 14 days))
  • Length of hospital stay.(Hospital stay: up to 1 month)
  • Quality of recovery (QoR-15).(QoR-15: Measured at baseline and 72 hours postoperatively.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

In Gyu Kwon

Assistant Professor

Gangnam Severance Hospital

研究点 (1)

Loading locations...

相似试验